NEW YORK (GenomeWeb) – An international team led by investigators in Canada, the UK, and the US has identified dozens of rare or low-frequency genetic contributors to human height, including versions of some variants suspected of affecting adult height by close to an inch.

"The genes affected by these genetic variations modulate, among other things, bone and cartilage development, and growth hormone production and activation," co-senior author Guillaume Lettre, a researcher affiliated with the University of Montreal and the Montreal Heart Institute, said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.